Soluble vaccinia virus protein that binds chemokines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6355252
SERIAL NO

09367781

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Use for novel chemokine-binding protein designated A41L, and chemokine-binding fragments thereof, for the treatment of conditions such as inflammation. The A41L protein beinds to chemokines in the CXC group.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OXXON THERAPEUTICS LIMITED25 MILTON PARK 2ND FLOOR PARK GATE OXFORD OX14 4SH

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ng, Aylwin Singapore, SG 6 17
Smith, Geoffrey Oxford, GB 34 577

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation